Zentrela Inc.

Zentrela Inc. is a Canadian neurotechnology pioneer and creator of the first true scientific method for measuring the actual psychoactive effects of cannabis. The company's slogan "Setting the standard for measuring the effects of cannabis" reflects its mission to advance the world’s understanding of cannabis by creating the largest scientific database of consumer cannabis experiences through Observational Studies. Founded in 2015 in Hamilton, Ontario by entrepreneur Israel Gasperin and supported by Dr. Dan Bosnyak, a University of McMaster neuroscientist with over 20 years of unique experience in EEG technology, Neuroscience and AI. Zentrela Inc.'s vision is to set the standard for measuring cannabis effects by becoming the most reliable and accurate provider of cannabis effect information. The company's proprietary neurotechnology platform, Cognalyzer, uses advanced machine learning algorithms to analyze consumer EEG data to power their consumer research. Their last investment reflects a $850.00K Seed Round investment at 11 February 2021 led by Jornic Ventures. In summary, Zentrela Inc. is poised to revolutionize the cannabis industry by providing scientifically-backed data on the psychoactive effects of cannabis and has garnered support from notable investors, positioning it as a promising player in the neurotechnology sector.